Literature DB >> 20624149

Step-forward randomization in multicenter emergency treatment clinical trials.

Wenle Zhao1, Jody Ciolino, Yuko Palesch.   

Abstract

The authors present a new centralized randomization method for multicenter emergency treatment clinical trials. With this step-forward method, treatment randomization for the next subject is performed immediately after the enrollment of the current subject. This design ensures the readiness of the treatment assignment for each subject at the point of study enrollment, and it simultaneously provides effective control on treatment assignments balance and distributions of covariates. The authors also discuss procedures of the step-forward randomization method along with its implementation for two National Institute of Neurological Disorders and Stroke-funded multicenter acute stroke trials, one double-blinded and one open-labeled. Advantages and limitations are presented based on experience gained in these two trials. (c) 2010 by the Society for Academic Emergency Medicine.

Entities:  

Mesh:

Year:  2010        PMID: 20624149      PMCID: PMC3052925          DOI: 10.1111/j.1553-2712.2010.00746.x

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  13 in total

1.  New technologies to improve clinical trials.

Authors:  K A Kobak; J H Greist; J W Jefferson; D J Katzelnick; J C Mundt
Journal:  J Clin Psychopharmacol       Date:  2001-06       Impact factor: 3.153

Review 2.  The problem of informed consent in emergency medicine research.

Authors:  B A Foëx
Journal:  Emerg Med J       Date:  2001-05       Impact factor: 2.740

3.  ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury.

Authors:  David W Wright; Arthur L Kellermann; Vicki S Hertzberg; Pamela L Clark; Michael Frankel; Felicia C Goldstein; Jeffrey P Salomone; L Leon Dent; Odette A Harris; Douglas S Ander; Douglas W Lowery; Manish M Patel; Donald D Denson; Angelita B Gordon; Marlena M Wald; Sanjay Gupta; Stuart W Hoffman; Donald G Stein
Journal:  Ann Emerg Med       Date:  2006-09-29       Impact factor: 5.721

4.  The use of noninvasive positive pressure ventilation in the emergency department: results of a randomized clinical trial.

Authors:  K A Wood; L Lewis; B Von Harz; M H Kollef
Journal:  Chest       Date:  1998-05       Impact factor: 9.410

5.  LY315920NA/S-5920, a selective inhibitor of group IIA secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsis.

Authors:  Bernhardt G Zeiher; Jay Steingrub; Pierre-Francois Laterre; Alex Dmitrienko; Yonetaka Fukiishi; Edward Abraham
Journal:  Crit Care Med       Date:  2005-08       Impact factor: 7.598

Review 6.  Recombinant tissue plasminogen activator (rtPA) for stroke. The perspective at 8 years.

Authors:  James L Frey
Journal:  Neurologist       Date:  2005-03       Impact factor: 1.398

7.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

8.  Tolerability of NXY-059 at higher target concentrations in patients with acute stroke.

Authors:  K R Lees; D Barer; G A Ford; W Hacke; V Kostulas; A K Sharma; T Odergren
Journal:  Stroke       Date:  2003-02       Impact factor: 7.914

9.  NINDS clinical trials in stroke: lessons learned and future directions.

Authors:  John R Marler
Journal:  Stroke       Date:  2007-10-25       Impact factor: 7.914

10.  Low-dose estradiol spray to treat vasomotor symptoms: a randomized controlled trial.

Authors:  John E Buster; William D Koltun; Maria Luz G Pascual; Wesley W Day; Craig Peterson
Journal:  Obstet Gynecol       Date:  2008-06       Impact factor: 7.661

View more
  9 in total

1.  Comparison of statistical and operational properties of subject randomization procedures for large multicenter clinical trial treating medical emergencies.

Authors:  Wenle Zhao; Yunming Mu; Darren Tayama; Sharon D Yeatts
Journal:  Contemp Clin Trials       Date:  2015-01-29       Impact factor: 2.226

2.  Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus.

Authors:  Jaideep Kapur; Jordan Elm; James M Chamberlain; William Barsan; James Cloyd; Daniel Lowenstein; Shlomo Shinnar; Robin Conwit; Caitlyn Meinzer; Hannah Cock; Nathan Fountain; Jason T Connor; Robert Silbergleit
Journal:  N Engl J Med       Date:  2019-11-28       Impact factor: 91.245

3.  Methodology of the Field Administration of Stroke Therapy - Magnesium (FAST-MAG) phase 3 trial: Part 2 - prehospital study methods.

Authors:  Jeffrey L Saver; Sidney Starkman; Marc Eckstein; Samuel Stratton; Frank Pratt; Scott Hamilton; Robin Conwit; David S Liebeskind; Gene Sung; Nerses Sanossian
Journal:  Int J Stroke       Date:  2014-02       Impact factor: 5.266

4.  The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2.

Authors:  Myron D Ginsberg; Yuko Y Palesch; Renee H Martin; Michael D Hill; Claudia S Moy; Bonnie D Waldman; Sharon D Yeatts; Diego Tamariz; Karla Ryckborst
Journal:  Stroke       Date:  2010-12-16       Impact factor: 7.914

5.  The Albumin in Acute Stroke Part 1 Trial: an exploratory efficacy analysis.

Authors:  Michael D Hill; Renee H Martin; Yuko Y Palesch; Diego Tamariz; Bonnie D Waldman; Karla J Ryckborst; Claudia S Moy; William G Barsan; Myron D Ginsberg
Journal:  Stroke       Date:  2011-05-05       Impact factor: 7.914

6.  ALIAS (Albumin in Acute Ischemic Stroke) Trials: Analysis of the Combined Data From Parts 1 and 2.

Authors:  Renee' H Martin; Sharon D Yeatts; Michael D Hill; Claudia S Moy; Myron D Ginsberg; Yuko Y Palesch
Journal:  Stroke       Date:  2016-07-26       Impact factor: 7.914

7.  Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus.

Authors:  Jason T Connor; Jordan J Elm; Kristine R Broglio
Journal:  J Clin Epidemiol       Date:  2013-08       Impact factor: 6.437

Review 8.  Lessons from the Established Status Epilepticus Treatment Trial.

Authors:  Hannah R Cock; Lisa D Coles; Jordan Elm; Robert Silbergleit; James M Chamberlain; James C Cloyd; Nathan Fountain; Shlomo Shinnar; Dan Lowenstein; Robin Conwit; Thomas P Bleck; Jaideep Kapur
Journal:  Epilepsy Behav       Date:  2019-10-22       Impact factor: 2.937

Review 9.  Randomization methods in emergency setting trials: a descriptive review.

Authors:  Mark Stephen Corbett; Thirimon Moe-Byrne; Sam Oddie; William McGuire
Journal:  Res Synth Methods       Date:  2015-09-02       Impact factor: 5.273

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.